Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.325
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.05 (3.846%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.325
XSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Warrants and Total Voting Rights

26 Jan 2024 13:35

RNS Number : 1033B
Xeros Technology Group plc
26 January 2024
 

26 January 2024

 

Xeros Technology Group plc

('Xeros", the "Company" or the "Group")

 

Exercise of Warrants

and

Total Voting Rights

 

Xeros Technology Group plc (AIM: XSG), the creator of technologies that reduce the impact of clothing on the planet, announces that further to the amendments to the terms of the warrants to subscribe for ordinary share of 0.1 pence each (respectively "Warrants" and "Ordinary Shares"), as approved by warrant holders on 21 December 2023, the Company has issued 12,450,041 new Ordinary Shares, following receipt of valid notices of exercise at the amended Warrant exercise price of 2.85 pence per share. The new Ordinary Shares so issued will be admitted to trading on AIM by way of the Company's existing block admission arrangements.

 

Warrant holders have until 5.00 pm on 31 January 2024 to exercise any remaining Warrants held by them.

 

The Company's issued share capital now consists of 164,935,363 Ordinary Shares with voting rights, with no shares held in treasury. This figure may therefore be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's share capital pursuant to (i) the Company's Articles, (ii) the Financial Conduct Authority's Disclosure Guidance and Transparency Rules and/or (iii) the AIM Rules for Companies issued by the London Stock Exchange plc as amended from time to time.

 

Enquiries

 

Xeros Technology Group plc

Neil Austin, Chief Executive Officer

Alex Tristram, Director of Finance

 

Tel: 0114 269 9656

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Julian Blunt/Teddy Whiley, Corporate Finance

Andrew Burdis/Sunila de Silva, ECM

 

Tel: 020 7220 0570

Belvedere PR

Cat Valentine

Keeley Clarke

xeros@belvederepr.com

Mob: 07715 769 078

Mob: 07967 816 525

 

About Xeros

 

Xeros Technology plc has developed patented and proven, industry-leading technologies which reduce the environmental impact of how industries make and care for clothes.

 

The traditional wet processing methods used in industrial and domestic laundry and garment manufacturing consume billions of litres of fresh water and large amounts of energy and chemicals, as well as damaging and weakening clothing fibres and creating rising levels of environmental pollution. It is estimated that washing machines contribute 35% of the 171 trillion microplastic particles in the ocean.

 

A range of actors, including consumers, the media NGOs and regulators are exerting pressure on these industries, with legislative action beginning to be taken.

 

Xeros' three main technologies, Filtration, Finish, and Care, facilitate garment manufacturers, industrial laundries, domestic washing machine manufacturers and consumers, to reduce their environmental impact, whilst also significantly improving efficiency in the process.

 

Xeros' model is to generate revenue from licensing its technologies, generating royalties and the sale of consumables. Currently there are 8 agreements in place. The addressable markets in Filtration, Finish and Care are estimated to be valued at £350m p.a., £132m p.a. and £3bn p.a. respectively.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRQKABNNBKDQDB
Date   Source Headline
22nd Jun 20227:00 amRNS2021 Preliminary Results
14th Jun 202211:05 amRNSSecond Price Monitoring Extn
14th Jun 202211:00 amRNSPrice Monitoring Extension
14th Jun 20227:01 amRNSDomestic XFilter Independent Test Validation
14th Jun 20227:00 amRNSFirst Global Domestic XFilter Licensing Agreement
8th Jun 20227:00 amRNSIFB Domestic Machine Launch Update
31st Mar 20224:41 pmRNSSecond Price Monitoring Extn
31st Mar 20224:35 pmRNSPrice Monitoring Extension
31st Mar 20222:05 pmRNSSecond Price Monitoring Extn
31st Mar 20222:00 pmRNSPrice Monitoring Extension
31st Mar 202211:05 amRNSSecond Price Monitoring Extn
31st Mar 202211:00 amRNSPrice Monitoring Extension
31st Mar 20227:00 amRNSTrading Update
18th Mar 20227:00 amRNSBoard Change
8th Feb 20221:03 pmRNSDirector/PDMR Transactions, Issue of Options
27th Jan 20227:00 amRNSBusiness Update
17th Jan 202210:19 amRNSApplication for Block Listing
13th Jan 20229:05 amRNSBlock Listing Six Monthly Return
23rd Sep 20217:00 amRNSInterim Results
7th Sep 202112:53 pmRNSNotice of Interim Results & Investor Presentation
11th Aug 202110:56 amRNSIndia Licensing Update
21st Jul 20214:40 pmRNSSecond Price Monitoring Extn
21st Jul 20214:35 pmRNSPrice Monitoring Extension
20th Jul 20217:00 amRNSDirectorate Change
7th Jul 202111:24 amRNSHolding(s) in Company
5th Jul 20213:37 pmRNSBlock Listing Six Monthly Return
1st Jul 20217:00 amRNSDomestic XFiltra co-operation agreement signed
29th Jun 20213:20 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFirst license agreement for XFiltra Technology
27th May 202110:43 amRNSResult of AGM
12th May 20217:00 amRNSCommercial Laundry Technology launches in China
4th May 20214:49 pmRNSPublication of Annual Report & Notice of AGM
29th Apr 20217:00 amRNS2020 Audited Results
13th Apr 202110:01 amRNSNotice of Results & Investor Presentation
31st Mar 20219:15 amRNSHolding(s) in Company
30th Mar 20212:47 pmRNSHolding(s) in Company
29th Mar 20213:50 pmRNSHolding(s) in Company
26th Mar 20216:04 pmRNSHolding(s) in Company
26th Mar 202112:18 pmRNSHolding(s) in Company
25th Mar 202110:45 amRNSResult of General Meeting and Total Voting Rights
24th Mar 20217:00 amRNSResult of Open Offer
12th Mar 20214:41 pmRNSSecond Price Monitoring Extn
12th Mar 20214:36 pmRNSPrice Monitoring Extension
5th Mar 20218:48 amRNSResult of Placing
5th Mar 20217:00 amRNSProposed Placing, Open Offer & Notice of GM
1st Feb 20214:41 pmRNSSecond Price Monitoring Extn
1st Feb 20214:35 pmRNSPrice Monitoring Extension
26th Jan 20219:30 amRNSDirector/PDMR Transactions, Issue of Options
15th Jan 20218:30 amRNSBlock Listing Six Monthly Return
11th Jan 20214:53 pmRNSApplication for Block Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.